Journal article · 2023 · Open access

Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution

Claire Guéguen, Thibaut Ben Chimol, Margaux Briand, Kassandra Renaud, Mélodie Seiler, Morgane Ziesel, Patrick Erbacher, Malik Hellal

European Journal of Pharmaceutics and Biopharmaceutics, 195, 114077 · Published 12 August 2023 · DOI 10.1016/j.ejpb.2023.08.002

Open full textCite this paper

In brief

“Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution” is a 2023 journal article by Claire Guéguen and 7 co-authors, published in European Journal of Pharmaceutics and Biopharmaceutics. OpenAlex counts 42 citations as of 21 November 2026, which puts it in the top 1% of works published in 2023 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at European Journal of Pharmaceutics and Biopharmaceutics.

Citations
42
Most cited in
2025 (19)
Field-weighted impact
2.95
References
34
Authors
8

Abstract

RNA therapeutics represents a powerful strategy for diseases where other approaches have failed, especially given the recent successes of mRNA vaccines against the coronavirus disease 2019 (COVID-19) and small interfering (siRNA) therapeutics. However, further developments are still required to reduce toxicity, improve stability and biodistribution of mRNA-LNPs (lipid nanoparticles). Here, we show a rational combinatorial approach to select the best formulation based on a new cationic lipid molecule (IM21.7c), which includes an imidazolium polar head. The study allowed us to select the optimal 5 lipids composition for in vivo mRNA delivery. IM21.7c based mRNA-LNPs measuring less than 100 nm had high encapsulation efficiency, protected mRNA from degradation, and exhibited sustained release kinetics for effective in vitro transfection. Most interestingly the biodistribution was significantly different from other clinically approved LNPs, with increased targeting to the lung. Further studies are now required to expand the possible applications of these new molecules.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Guéguen, C., Chimol, T. B., Briand, M., Renaud, K., Seiler, M., Ziesel, M., Erbacher, P., & Hellal, M. (2023). Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution. European Journal of Pharmaceutics and Biopharmaceutics, 195, 114077. https://doi.org/10.1016/j.ejpb.2023.08.002

MLA 9

Guéguen, Claire, et al. “Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution.” European Journal of Pharmaceutics and Biopharmaceutics, vol. 195, 2023, p. 114077. https://doi.org/10.1016/j.ejpb.2023.08.002.

Chicago

Guéguen, Claire, Thibaut Ben Chimol, Margaux Briand, Kassandra Renaud, Mélodie Seiler, Morgane Ziesel, Patrick Erbacher, and Malik Hellal. 2023. “Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution.” European Journal of Pharmaceutics and Biopharmaceutics 195: 114077. https://doi.org/10.1016/j.ejpb.2023.08.002.

Harvard

Guéguen, C. et al. (2023) ‘Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution’, European Journal of Pharmaceutics and Biopharmaceutics, 195, p. 114077. doi:10.1016/j.ejpb.2023.08.002.

IEEE

C. Guéguen et al., “Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 195, p. 114077, 2023, doi: 10.1016/j.ejpb.2023.08.002.

BibTeX

@article{gueguen2023evaluating,
  title     = {{Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution}},
  author    = {Guéguen, Claire and Chimol, Thibaut Ben and Briand, Margaux and Renaud, Kassandra and Seiler, Mélodie and Ziesel, Morgane and Erbacher, Patrick and Hellal, Malik},
  journal   = {European Journal of Pharmaceutics and Biopharmaceutics},
  year      = {2023},
  volume    = {195},
  pages     = {114077},
  doi       = {10.1016/j.ejpb.2023.08.002},
  url       = {https://doi.org/10.1016/j.ejpb.2023.08.002}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20241313
20251919
20261010

Its field-weighted citation impact is 2.95: it has been cited 2.95 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • cationic lipids
  • lipid nanoparticles
  • mRNA delivery
  • RNA therapeutics
  • imidazolium
  • encapsulation efficiency
  • mRNA stability
  • sustained drug release

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Guéguen, C., Chimol, T. B., Briand, M., Renaud, K., Seiler, M., Ziesel, M., Erbacher, P., & Hellal, M. (2023). Evaluating how cationic lipid affects mRNA-LNP physical properties and biodistribution. European Journal of Pharmaceutics and Biopharmaceutics, 195, 114077. https://doi.org/10.1016/j.ejpb.2023.08.002

How many times has this paper been cited?

42 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at European Journal of Pharmaceutics and Biopharmaceutics: sign in and open the full text from this page.

Who wrote this paper?

Claire Guéguen, Thibaut Ben Chimol, Margaux Briand, Kassandra Renaud, Mélodie Seiler, Morgane Ziesel, Patrick Erbacher, Malik Hellal.

What is the DOI of this paper?

10.1016/j.ejpb.2023.08.002, permanently at https://doi.org/10.1016/j.ejpb.2023.08.002. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.